Zolunicant (MM-110) is a potent inhibitor against nicotinic alpha3beta4 receptors with an IC50 of 0.90 µM to combat addiction. Zolunicant can decrease the self-administration of several addictive agents including morphine, methamphetamine, nicotine, and ethanol in rat model. Zolunicant can be studied as a potential research for multiple forms of agent abuse[1]. Zolunicant also reveals a potent leishmanicide effect against Leishmania amazonensis[2].
Molekulargewicht:
368.47
Reinheit:
99.29
CAS Nummer:
[188125-42-0]
Formel:
C22H28N2O3
Target-Kategorie:
nAChR,Parasite
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
